Chemosensitivity and ventilatory inefficiency in pulmonary vascular diseases

J. Weatherald (Calgary, AB, Canada)

Source: International Congress 2017 – The lungs and the heart during exercise
Session: The lungs and the heart during exercise
Session type: Oral Presentation
Number: 1966
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Weatherald (Calgary, AB, Canada). Chemosensitivity and ventilatory inefficiency in pulmonary vascular diseases. 1966

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Patterns of cardiopulmonary response to exercise in pulmonary vascular diseases
Source: Eur Respir Monogr 2018; 80: 160-174
Year: 2018


Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Pulmonary vascular diseases
Source: ERS Course 2015
Year: 2015

Pulmonary vascular diseases
Source: ERS Skills Course 2016
Year: 2016

Patterns of cardiopulmonary response to exercise in lung diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69
Year: 2007

CPET in pulmonary vascular disease
Source: ERS Skills course - Clinical exercise testing: advanced
Year: 2018

Pulmonary vascular and cardiac impairment in interstitial lung disease
Source: Eur Respir Rev 2017; 26: 160128
Year: 2017



Distinguishing pulmonary hypertension in interstitial lung disease by ventilation and perfusion defects as measured by cardiopulmonary exercise testing
Source: Annual Congress 2012 - Exercise testing in disease
Year: 2012


Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Pulmonary vascular response patterns during exercise in interstitial lung disease
Source: Eur Respir J 2015; 46: 738-749
Year: 2015



Updates in pulmonary hypertension and other pulmonary vascular diseases
Source: Breathe, 15 (3) 241; 10.1183/20734735.0187-2019
Year: 2019



Beta-blocker therapy nor hyperoxic breathing lowers ventilatory drive in pulmonary arterial hypertension patients
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014


COVID-19 and the pulmonary circulation
Source: ERS webinar 2020: COVID-19 and the pulmonary circulation
Year: 2020


Pulmonary hypertensive vasculopathy in parenchymal lung diseases and/or hypoxia
Source: Eur Respir Rev, 26 (144) 170003; 10.1183/16000617.0003-2017
Year: 2017



Pulmonary hypertension in chronic lung disease and hypoxia
Source: Eur Respir J, 53 (1) 1801914; 10.1183/13993003.01914-2018
Year: 2019



Exertional ventilatory and gas exchange inefficiency: contrasting interstitial versus pulmonary vascular disease
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020


Interactions between the pulmonary and the bronchial circulation in pulmonary diseases
Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy
Year: 2016

Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency
Source: Eur Respir Rev, 30 (162) 200355; 10.1183/16000617.0355-2020
Year: 2021